Literature DB >> 15078130

Recent development and application of virtual screening in drug discovery: an overview.

Tingjun Hou1, Xiaojie Xu.   

Abstract

Virtual screening, especially the structure-based virtual screening, has emerged as a reliable, cost-effective and time-saving technique for the discovery of lead compounds. Here, the basic ideas and computational tools for virtual screening have been briefly introduced, and emphasis is placed on aspects of recent development of docking-based virtual screening, scoring functions in molecular docking and ADME/Tox-based virtual screening in the past three years (2000 to 2003). Moreover, successful examples are provided to further demonstrate the effectiveness of virtual screening in drug discovery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078130     DOI: 10.2174/1381612043452721

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  36 in total

1.  Amoebicidal activity of the rhizomes and aerial parts of Allium sivasicum on Entamoeba histolytica.

Authors:  S Degerli; S Berk; B Tepe; E Malatyali
Journal:  Parasitol Res       Date:  2012-01-04       Impact factor: 2.289

2.  Permuting input for more effective sampling of 3D conformer space.

Authors:  Giorgio Carta; Valeria Onnis; Andrew J S Knox; Darren Fayne; David G Lloyd
Journal:  J Comput Aided Mol Des       Date:  2006-07-14       Impact factor: 3.686

Review 3.  Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.

Authors:  I M Kapetanovic
Journal:  Chem Biol Interact       Date:  2006-12-16       Impact factor: 5.192

Review 4.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Fragment virtual screening based on Bayesian categorization for discovering novel VEGFR-2 scaffolds.

Authors:  Yanmin Zhang; Yu Jiao; Xiao Xiong; Haichun Liu; Ting Ran; Jinxing Xu; Shuai Lu; Anyang Xu; Jing Pan; Xin Qiao; Zhihao Shi; Tao Lu; Yadong Chen
Journal:  Mol Divers       Date:  2015-05-29       Impact factor: 2.943

6.  Molecular recognition in the case of flexible targets.

Authors:  Anthony Ivetac; J Andrew McCammon
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

7.  Covalent Antiviral Agents.

Authors:  Sako Mirzaie; Fatemeh Abdi; Amin GhavamiNejad; Brian Lu; Xiao Yu Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Orphan Receptor GPR88 as an Emerging Neurotherapeutic Target.

Authors:  Na Ye; Bang Li; Qi Mao; Eric A Wold; Sheng Tian; John A Allen; Jia Zhou
Journal:  ACS Chem Neurosci       Date:  2018-12-20       Impact factor: 4.418

9.  Combining substrate dynamics, binding statistics, and energy barriers to rationalize regioselective hydroxylation of octane and lauric acid by CYP102A1 and mutants.

Authors:  K Anton Feenstra; Eugene B Starikov; Vlada B Urlacher; Jan N M Commandeur; Nico P E Vermeulen
Journal:  Protein Sci       Date:  2007-03       Impact factor: 6.725

10.  Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.

Authors:  Lili Chen; Chunshan Gui; Xiaomin Luo; Qingang Yang; Stephan Günther; Elke Scandella; Christian Drosten; Donglu Bai; Xichang He; Burkhard Ludewig; Jing Chen; Haibin Luo; Yiming Yang; Yifu Yang; Jianping Zou; Volker Thiel; Kaixian Chen; Jianhua Shen; Xu Shen; Hualiang Jiang
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.